Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
ViewRay Inc (ViewRay) is a medical device company that develops radiation therapy technology for the treatment of cancer. It provides MRIdian, a radiation therapy solution that enables treatment and real-time imaging of a patient’s anatomy simultaneously. The company offers MRIdian to integrate MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors although radiation is delivered. ViewRay’s technology MRIdian Linac uses the same split-magnet MRI system used in the MRIdian, which is designed to fit in standard radiotherapy vaults replacing X-ray guided linear accelerators. The company caters services to university research and teaching hospitals, community hospitals, private practices, government institutions and freestanding cancer centers, among others. ViewRay is headquartered in Oakwood Village, Ohio, the US
Headquarters
United States of America
Address
2 Thermo Fisher Way, Oakwood Village, Ohio, 44146-6536
Telephone
1 440 7033210
No of Employees
295
Industry
Medical Equipment
Ticker Symbol & Exchange
VRAYQ (OTC)
Revenue (2022)
$102.2M
45.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
2.5%
(2022 vs 2021)
Net Profit Margin (2022)
XYZ
33.1%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Products |
|---|
| MRIdian System |
| MRIdian Linac System |
Competitor Comparison
| Key Parameters | ViewRay Inc | Elekta AB | Accuray Inc | Raysearch Laboratories AB | Advanced Imaging Research Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Sweden | United States of America | Sweden | United States of America |
| City | Oakwood Village | Stockholm | Madison | Stockholm | Cleveland |
| State/Province | Ohio | - | Wisconsin | - | Ohio |
| No. of Employees | 295 | 4,536 | 990 | 408 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer